NMR in Biomedicine, Vol. 12, No. 3. (1999), pp. 123-138.
Journal of Immunological Methods, Vol. 193, No. 1. (14 June 1996), pp. 93-99.
Clin Cancer Res, Vol. 8, No. 9. (1 September 2002), pp. 2766-2774.
Biochimie, Vol. 77, No. 5. (1995), pp. 378-384.
J Biol Chem, Vol. 280, No. 17. (29 April 2005), pp. 17227-17234.
Cell, Vol. 75, No. 2. (22 October 1993), pp. 241-251.
Mol Imaging, Vol. 3, No. 1. (January 2004), pp. 1-8.
Chemico-Biological Interactions, Vol. In Press, Corrected Proof
Magn Reson Med, Vol. 40, No. 3. (September 1998), pp. 411-420.
Bioconjug Chem, Vol. 15, No. 5. (t 2004), pp. 983-987.
Nature, Vol. 405, No. 6782. (4 May 2000), pp. 85-90.
Endocr Rev, Vol. 14, No. 2. (1 April 1993), pp. 133-151.
Prog Neuropsychopharmacol Biol Psychiatry, Vol. 27, No. 2. (April 2003), pp. 323-331.
Science, Vol. 281, No. 5381. (28 August 1998), pp. 1312-1316.
Biochem Soc Symp, No. 70. (2003), pp. 233-242.
Cancer Cell, Vol. 9, No. 5. (May 2006), pp. 351-365.
Nature, Vol. 432, No. 7015. (18 November 2004), pp. 307-315.
PNAS, Vol. 99, No. 10. (14 May 2002), pp. 6871-6876.
Nature, Vol. 407, No. 6805. (12 October 2000), pp. 784-788.
Anticancer Drugs, Vol. 6, No. 3. (June 1995), pp. 443-450.
Cancer J, Vol. 9, No. 1. (b 2003), pp. 33-41.
by TA
Buchholz, DW
Davis, DJ
McConkey, WF
Symmans, V
Valero, A
Jhingran, SL
Tucker, L
Pusztai, M
Cristofanilli, FJ
Esteva, GN
Hortobagyi, AA
Sahin
Lancet, Vol. 349, No. 9055. (22 March 1997)
Radiother Oncol, Vol. 46, No. 2. (February 1998), pp. 185-191.
Cancer, Vol. 89, No. 11. (2000), pp. 2145-2152.
Exp Cell Res, Vol. 248, No. 1. (10 April 1999), pp. 30-43.
Mol Cancer Ther, Vol. 2, No. 3. (March 2003), pp. 333-334.
European Journal of Surgical Oncology, Vol. 32, No. 3. (April 2006), pp. 269-277.
Magn Reson Med, Vol. 54, No. 1. (July 2005), pp. 43-50.